Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713199 | SCV000843785 | uncertain significance | not provided | 2017-10-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713199 | SCV001155788 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002397497 | SCV002714309 | uncertain significance | Inborn genetic diseases | 2023-09-25 | criteria provided, single submitter | clinical testing | The c.1754A>G (p.Q585R) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a A to G substitution at nucleotide position 1754, causing the glutamine (Q) at amino acid position 585 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002532950 | SCV003281856 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-05-01 | criteria provided, single submitter | clinical testing |